Mayo Clinic News Network

News Resources


Share this:

Posted by Nick Hanson (@nickhanson) · Tue, Mar 18 at 10:12am EST

COPD Associated With Increased Risk for Mild Cognitive Impairment

Bottom Line:  A diagnosis of chronic obstructive pulmonary disease (COPD) in older adults was associated with increased risk for mild cognitive impairment (MCI), especially MCI of skills other than memory, and the greatest risk was among patients who had COPD for more than five years. The study is published in JAMA Neurology.

Authors:  Balwinder Singh, M.D., M.S., and Michelle Mielke, Ph.D., of the Mayo Clinic, Rochester, Minn., and colleagues.

Background: COPD is an irreversible limitation of airflow into the lungs, usually caused by smoking. More than 13.5 million adults 25 years or older in the U.S. have COPD. Previous research has suggested COPD is associated with cognitive impairment.

How the Study Was Conducted: The authors examined the association between COPD and MCI, as well as the duration of MCI, in 1,425 individuals (ages 70 to 89 years) with normal cognition in 2004 from Olmsted County, Minn. At baseline, 171 patients had a COPD diagnosis.

Results: Of the 1,425 patients, 370 developed MCI: 230 had amnestic MCI (A-MCI, which affects memory), 97 had nonamnestic MCI (NA-MCI), 27 had MCI of an unknown type and 16 had progressed from normal cognition to dementia. A diagnosis of COPD increased the risk for NA-MCI by a relative 83 percent during a median of 5.1 years of follow-up. Patients who had COPD for more than five years had the greatest risk for MCI.

Alzheimer's Alzheimer’s disease COPD JAMA Neurology MCI Michelle Mielke mild cognitive impairment Minnesota news release News Release REP Rochester Epidemiology Project smoking

 

Have something to say? Please login or register to respond.